JP2017129381A5 - - Google Patents

Download PDF

Info

Publication number
JP2017129381A5
JP2017129381A5 JP2016007208A JP2016007208A JP2017129381A5 JP 2017129381 A5 JP2017129381 A5 JP 2017129381A5 JP 2016007208 A JP2016007208 A JP 2016007208A JP 2016007208 A JP2016007208 A JP 2016007208A JP 2017129381 A5 JP2017129381 A5 JP 2017129381A5
Authority
JP
Japan
Prior art keywords
human
antibody
antibodies
bound
coloring solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016007208A
Other languages
English (en)
Japanese (ja)
Other versions
JP6733079B2 (ja
JP2017129381A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2016007208A priority Critical patent/JP6733079B2/ja
Priority claimed from JP2016007208A external-priority patent/JP6733079B2/ja
Publication of JP2017129381A publication Critical patent/JP2017129381A/ja
Publication of JP2017129381A5 publication Critical patent/JP2017129381A5/ja
Application granted granted Critical
Publication of JP6733079B2 publication Critical patent/JP6733079B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016007208A 2016-01-18 2016-01-18 試料中の抗糖脂質抗体の測定試薬及び測定方法 Active JP6733079B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016007208A JP6733079B2 (ja) 2016-01-18 2016-01-18 試料中の抗糖脂質抗体の測定試薬及び測定方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016007208A JP6733079B2 (ja) 2016-01-18 2016-01-18 試料中の抗糖脂質抗体の測定試薬及び測定方法

Publications (3)

Publication Number Publication Date
JP2017129381A JP2017129381A (ja) 2017-07-27
JP2017129381A5 true JP2017129381A5 (enExample) 2019-05-09
JP6733079B2 JP6733079B2 (ja) 2020-07-29

Family

ID=59394663

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016007208A Active JP6733079B2 (ja) 2016-01-18 2016-01-18 試料中の抗糖脂質抗体の測定試薬及び測定方法

Country Status (1)

Country Link
JP (1) JP6733079B2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019162273A (ja) * 2018-03-19 2019-09-26 株式会社三洋物産 遊技機
JP2019162276A (ja) * 2018-03-19 2019-09-26 株式会社三洋物産 遊技機
JP2019162277A (ja) * 2018-03-19 2019-09-26 株式会社三洋物産 遊技機
JP2019162275A (ja) * 2018-03-19 2019-09-26 株式会社三洋物産 遊技機
JP2019162274A (ja) * 2018-03-19 2019-09-26 株式会社三洋物産 遊技機
JP2019162269A (ja) * 2018-03-19 2019-09-26 株式会社三洋物産 遊技機
JP2019162272A (ja) * 2018-03-19 2019-09-26 株式会社三洋物産 遊技機
JP2019162271A (ja) * 2018-03-19 2019-09-26 株式会社三洋物産 遊技機
JP2019162270A (ja) * 2018-03-19 2019-09-26 株式会社三洋物産 遊技機

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02138872A (ja) * 1988-11-18 1990-05-28 Asahi Chem Ind Co Ltd 癌関連物質のための免疫測定方法
JPH09178749A (ja) * 1995-12-22 1997-07-11 Shinotesuto:Kk ポリ塩化ビニルよりなる担体を用いるヒト抗糖脂質抗体測定試薬及び測定方法
JP4524446B2 (ja) * 2002-03-31 2010-08-18 株式会社シノテスト 糖脂質抗原の活性化剤及び活性化方法、並びに試料中の抗糖脂質抗体の測定方法及び測定試薬キット
EP1369693A1 (de) * 2002-06-04 2003-12-10 B.R.A.H.M.S Aktiengesellschaft Verfahren zur Sepsisdiagnose und zur Kontrolle von Spenderblut durch Bestimmung von anti-Asialo-Gangliosid-Antikörpern
JP2007322310A (ja) * 2006-06-02 2007-12-13 Nippon Kayaku Co Ltd 検体中の分析対象物質の検出あるいは測定方法

Similar Documents

Publication Publication Date Title
JP2017129381A5 (enExample)
HRP20191609T1 (hr) Protein
HRP20250807T1 (hr) Protutijela koja vežu ljudski cgrp receptor
TR201901929T4 (tr) TGFBeta'ya antikorlar.
NZ703035A (en) Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
PL3882275T3 (pl) Przeciwciało dwufunkcyjne anty-pd-1 i anty-vegfa, kompozycja farmaceutyczna i zastosowanie tych przeciwciał
HRP20181069T1 (hr) Antagonistička protutijela na il-17
CA2849765C (en) Hybrid constant regions
EA201100527A1 (ru) Биологические продукты
WO2017132562A8 (en) Antigen binding proteins that bind pd-l1
BRPI0611414B8 (pt) anticorpo ou fragmento de ligação ao antígeno do mesmo que se liga ao tweak humano, composição farmacêutica e seus usos
ES2523194T3 (es) Anticuerpo monoclonal humano específico para cada tumor
BR112016022841A8 (pt) Anticorpo igm, iga, igg / igm ou igg / iga, ou um fragmento de ligação ao antígeno do mesmo, composição que o compreende e uso do mesmo
JP2015524821A5 (enExample)
HRP20221262T1 (hr) Protutijela anti-pd1 i njihova uporaba kao terapeutskih i dijagnostičkih sredstava
EP4434543A3 (en) Human igg1 fc region variants and uses thereof
HRP20201191T1 (hr) Mutirani multispecifični fab fragmenti antitijela
MX386942B (es) Anticuerpos que comprenden regiones constantes pesadas modificadas.
WO2017152102A3 (en) Anti-trem1 antibodies and methods of use thereof
EA201792657A1 (ru) Связывающие lag-3 молекулы и способы их применения
PE20121249A1 (es) Inmunoglobulinas con dominio variable dual
HRP20241779T1 (hr) Molekule koje se vežu na antigen, koje potiču klirens antigena
WO2016201389A3 (en) Anti-cd33 antibodies and methods of use thereof
DOP2011000404A (es) Polipeptidos y metodo de tratamiento
EA201001467A1 (ru) Моноклональное антитело и способ его использования